IBA Group, which develops cancer diagnosis and therapy technologies, and Royal Philips Electronics have entered into an agreement to create patient-centric proton therapy centers.
The IBA-Philips proton center concept is the first of its kind, and is initially being developed for the Middle East market, with subsequent plans to expand its use globally. Named ‘Proteus TK2’, the IBA-Philips center design encompasses elements to build a complete proton therapy center. This includes the building exterior and interior architecture, two IBA proton therapy treatment rooms, Philips Ambient Experience Design solutions, Philips CT, CT SIM, MRI technologies and patient monitoring equipment.
IBA and Philips are presenting their plans together at the European Society of Therapeutic Radiology and Oncology (ESTRO) anniversary congress in London, May 8 to 12 and the Particle Therapy Co-Operative Group (PTCOG) conference in Philadelphia, May 8 to 14.